Skip to main content

Advertisement

SpringerLink
Log in

Measurement of cholesterol in plasma and other body fluids

  • Published:
Current Atherosclerosis Reports Aims and scope Submit manuscript

Abstract

Measurement of cholesterol has become increasingly important with recognition of its predictive association with cardiovascular diseases. Government and professional groups in the United States and other countries have developed consensus guidelines for using cholesterol and the lipoproteins in identifying patients at risk and in managing therapies. Accuracy in the measurements is essential not only for reliable classification of patients, but also in public health/wellness programs and in research. Laboratory experts have developed requisite analytical performance targets and guidelines for measurements. Manufacturers of diagnostic reagents and laboratories can assure accuracy by accessing the Cholesterol Reference Method Laboratory Network, which offers reference methods for total, high-density lipoprotein, and low-density lipoprotein cholesterol. Recommendations for controlling pre-analytical sources of variation and uniform interpretation of patient results facilitate reliable classification of patients. Driven by increasing workloads and the need for increased efficiency in laboratory testing, dramatic improvements have been made in recent years in automating laboratory analyzers, as well as the methods used for lipoprotein analysis. Newer technology allows multiple sequential measurements in the same cuvette, as well as point-of-care measurements, using strip tests and compact analyzers. Efforts continue to develop reliable, minimally invasive tests in body fluids other than serum.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Expert Panel: Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001, 285:2486–2497.

    Article  Google Scholar 

  2. National Cholesterol Education Program Laboratory Standardization Panel: Current status of blood cholesterol measurements in clinical laboratories in the United States. Clin Chem 1988, 34:193–201.

    Google Scholar 

  3. Warnick GR, Wood P: National Cholesterol Education Program Recommendations for Measurement of High-Density Lipoprotein Cholesterol: Executive Summary. Clin Chem 1995, 41:1427–1433.

    PubMed  CAS  Google Scholar 

  4. Bachorik PS, Ross JW: National Cholesterol Education Program Recommendations for Measurement of Low-Density Lipoprotein Cholesterol: Executive Summary. Clin Chem 1995, 41:1414–1420.

    PubMed  CAS  Google Scholar 

  5. Miller WG: Matrix effects in the measurement and standardization of lipids and lipoproteins. In Handbook of Lipoprotein Testing. Edited by Rifai N, Warnick GR, Dominiczak MH. Washington, DC: AACC Press; 2000:695–716.

    Google Scholar 

  6. Myers GL, Cooper GR, Henderson LO, et al.: Standardization of lipid and lipoprotein measurement. In Handbook of Lipoprotein Testing. Edited by Rifai N, Warnick GR, Dominiczak MH. Washington, DC: AACC Press; 2000:717–748.

    Google Scholar 

  7. Myers GL, Kimberly MM, Waymack PP, et al.: A reference method laboratory network for cholesterol: a model for standardization and improvement of clinical laboratory measurements. Clin Chem 2000, 46:1762–1772.

    PubMed  CAS  Google Scholar 

  8. Cooper GR, Myers GL, Smith SJ, Schlant RC: Blood and lipid measurements variations and practical utility. JAMA 1992, 267:1652–1660.

    Article  PubMed  CAS  Google Scholar 

  9. Kroll MH, Cole TG, Rifai N, et al.: Standardization of lipoprotein reporting. Arch Pathol Lab Med 2000, 114:696–702.

    CAS  Google Scholar 

  10. Artiss JD, Zak B: Measurement of cholesterol concentration. In Handbook of Lipoprotein Testing. Edited by Rifai N, Warnick GR, Dominiczak MH. Washington, DC: AACC Press; 2000:189–205.

    Google Scholar 

  11. Warnick, GR: Measurement of HDL-cholesterol by homogeneous assays. Diag Endocrinol Immunol Metab 1999, 17:235–242.

    Google Scholar 

  12. Matthias N, Wiebe D, Warnick GR: Measurement of high-density-lipoprotein cholesterol. In Handbook of Lipoprotein Testing. Edited by Rifai N, Warnick GR, Dominiczak MH. Washington, DC: AACC Press; 2000:221–244.

    Google Scholar 

  13. Warnick G, Nauck M, Rifai N: Evolution of methods for measurement of high-density lipoprotein cholesterol: from ultracentrifugation to homogeneous assays. Clin Chem 2001, in press.

  14. Burstein M, Scholnick HR, Morfin R: Rapid method for the isolation of lipoproteins for human serum by precipitation with polyanions. J Lipid Res 1970, 11:583–595.

    PubMed  CAS  Google Scholar 

  15. Lopes-Virella MF, Stone P, Ellis S, Colwell JA: Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem 1977, 23:882–884.

    PubMed  CAS  Google Scholar 

  16. Warnick GR, Cheung MC, Albers JJ: Comparison of current methods for high-density lipoprotein cholesterol quantitation. Clin Chem 1979, 25:596–604.

    PubMed  CAS  Google Scholar 

  17. Warnick GR, Benderson J, Albers JJ, et al.: Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem 1982, 28:1379–1388.

    PubMed  CAS  Google Scholar 

  18. Demacker PN, Vos-Janssen HE, Hijmans AG, et al.: Measurement of high-density lipoprotein cholesterol in serum: comparison of six isolation methods combined with enzymatic cholesterol analysis. Clin Chem 1980, 26:A1780–1786.

    Google Scholar 

  19. Warnick GR, Albers JJ, Bachorik PS, et al.: Multi-laboratory evaluation of an ultrafiltration procedure for high density lipoprotein cholesterol quantification in turbid heparin-manganese supernates. J Lipid Res 1981, 22:1015–1019.

    PubMed  CAS  Google Scholar 

  20. Nauck M, März W, Wieland H: New immunoseparation-based homogeneous assay for HDL-cholesterol compared with three homogeneous and two heterogeneous methods for HDL-cholesterol. Clin Chem 1998, 44:1443–1451.

    PubMed  CAS  Google Scholar 

  21. Kakuyama T, Kimura S, Hasiguchi Y: Fully automated determination of HDL-cholesterol from human serum with Hitachi 911 [abstract]. Clin Chem 1994, 40:1104.

    Google Scholar 

  22. Nauck M, Marz W, Haas B, Wieland H: Homogeneous assay for direct determination of high-density lipoprotein cholesterol evaluated. Clin Chem 1996, 42:424–429.

    PubMed  CAS  Google Scholar 

  23. Sugiuchi H, Uji Y, Okabe H, et al.: Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated alpha-cyclodextrin. Clin Chem 1995, 41:717–723.

    PubMed  CAS  Google Scholar 

  24. Harris N, Galpachian V, Thomas J, et al.: Three generations of high-density lipoprotein cholesterol assays compared with ultracentrifugation/dextran sulfate-Mg2+ method. Clin Chem 1997, 43:816–823.

    PubMed  CAS  Google Scholar 

  25. de Keijzer M, Elbers D, Baadenhuijsen H, et al.: Evaluation of five different high-density lipoprotein cholesterol assays: the most precise are not the most accurate. Ann Clin Biochem 1999, 36:168–175.

    PubMed  Google Scholar 

  26. Izawa S, Okada M, Matsui H, Horita Y: A new direct method for measuring HDL-cholestrol which does not produce any biased values. J Med Pharm Sci 1997, 37:1385–1388.

    CAS  Google Scholar 

  27. Okazaki M, Sasamoto K, Muramatsu T, Hosaki S: Evaluation of precipitation and direct methods for HDL-cholesterol assay by HPLC. Clin Chem 1997, 43:1885–1890.

    PubMed  CAS  Google Scholar 

  28. Arranz-Pena ML, Tasende-Mata J, Martin-Gil FJ: Comparison of two homogeneous assays with a precipitation method and an ultracentrifugation method for the measurement of HDL-cholesterol. Clin Chem 1998, 44:2499–2505.

    PubMed  CAS  Google Scholar 

  29. Harris N, Galpchian V, Rafai N: Three routine methods for measuring high-density lipoprotein cholesterol compared with the Reference Method. Clin Chem 1996, 42:738–743.

    PubMed  CAS  Google Scholar 

  30. Halloran P, Roetering H, Pisani T, et al.: Reference standardization and analytical performance of a liquid homogeneous HDL-cholesterol method compared to a chemical precipitation method. Arch Pathol Lab Med 1999, 23:317–326.

    Google Scholar 

  31. Roberts WL, Leary ET, Lambert TL, et al.: Falsely low direct HDL-cholesterol results in a patient with dysbetalipoproteinemia. Clin Chem 2000, 46:560–564.

    PubMed  CAS  Google Scholar 

  32. Nauck M, Warnick GR, Rifai N: Methods for measurement of low-density lipoprotein cholesterol: a critical assessment of direct measurement by homogeneous assay versus calculation. Clin Chem 2001, submitted.

  33. McNamara JR, Cohn JS, Wilson PW, Schaefer EJ: Calculated values for low-density lipoprotein cholesterol in the assessment of lipid abnormalities and coronary disease risk. Clin Chem 1990, 36:36–42.

    PubMed  CAS  Google Scholar 

  34. Sugiuchi H, Irie T, Uji Y, et al.: Homogeneous assay for measuring low-density lipoprotein cholesterol in serum with triblock copolymer and alpha-cyclodextrin sulfate. Clin Chem 1998, 44:522–531.

    PubMed  CAS  Google Scholar 

  35. Miki Y: A homogeneous assay for the selective measurement of LDL-cholesterol in serum. Enzymatic selective protection method. Clin Lab 1999, 45:398–401.

    Google Scholar 

  36. Esteban-Salan M, Guimon-Bardesi A, de La Viuda-Unzueta J, et al.: Analytical and clinical evaluation of two homogeneous assays for LDL-cholesterol in hyperlipidemic patients. Clin Chem 2000, 46:1121–1131.

    PubMed  CAS  Google Scholar 

  37. Nauck M, Graziani M, Bruton D, et al.: Analytical and clinical performance of a detergent-based homogeneous LDL cholesterol assay: a multicenter evaluation. Clin Chem 2000, 46:506–514.

    PubMed  CAS  Google Scholar 

  38. Nauck M, Rifai N: Analytical performance and clinical efficacy of three routine procedures for LDL cholesterol measurement compared with the ultracentrifugation-dextran sulfate-Mg(2+) method. Clin Chim Acta 2000, 294:77–92.

    Article  PubMed  CAS  Google Scholar 

  39. Leary ET, Wang T, Baker DJ, et al.: Evaluation of an immunoseparation method for quantitative measurement of remnant-like particle-cholesterol in serum and plasma. Clin Chem 1998, 44:2490–2498.

    PubMed  CAS  Google Scholar 

  40. McNamara JR, Shah PK, Nakajima K, et al.: Remnant lipoprotein cholesterol and triglyceride reference ranges from the Framingham Heart Study. Clin Chem 1998, 44:1224–1232.

    PubMed  CAS  Google Scholar 

  41. Hoefner DM, Hodel SD, O’Brien JF, et al.: Development of a rapid, quantitative method for LDL subfractionation with use of the Quantimetrix Lipoprint LDL System. Clin Chem 2001, 47:266–274.

    PubMed  CAS  Google Scholar 

  42. Sampson ML, Aubrey A, Csako G, Remaley AT: Triple lipid screening test: a homogenous assay for HDL-cholesterol, total cholesterol and triglycerides. Clin Chem 2001, 47:532–539.

    PubMed  CAS  Google Scholar 

  43. Otvos JD, Jeyarajah EJ, Bennet DW, Krauss RM: Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement. Clin Chem 1992, 38:1632–1633.

    PubMed  CAS  Google Scholar 

  44. Freedman DS, Otvos JD, Jeyarajah EJ, et al.: Relation of lipoprotein subclasses as measured by proton magnetic resonance spectroscopy to coronary artery disease. Arterioscler Thromb Vasc Biol 1998, 18:1046–1053.

    PubMed  CAS  Google Scholar 

  45. Warnick GR: Compact analysis systems for cholesterol, triglycerides and high-density lipoprotein cholesterol. Curr Opin Lipidol 1991, 2:343–348.

    Article  CAS  Google Scholar 

  46. Bachorik PS: Lipid and lipoprotein analysis with desk-top analyzers. In Handbook of Lipoprotein Testing. Edited by Rifai N, Warnick GR, Dominiczak MH. Washington, DC: AACC Press; 2000:265–286.

    Google Scholar 

  47. Plessis MD, Ubbink JB, Hayward V: Analytical quality of near-patient blood cholesterol and glucose determinations. Clin Chem 2000, 46:1085–1090.

    PubMed  CAS  Google Scholar 

  48. Paek SH, Jang MR, Mok RS, et al.: Immunochromatographic membrane strip assay system for a single-class plasma lipoprotein cholesterol, exemplified by high-density lipoprotein cholesterol measurement. Biotech Bioeng 1999, 62:145–154.

    Article  CAS  Google Scholar 

  49. Kafonek SD, Donovan L, Lovejoy KL, Bachorik PS: Biological variation of lipids and lipoproteins in fingerstick blood. Clin Chem 1996, 42:2002–2007.

    PubMed  CAS  Google Scholar 

  50. Lopukhin YM: The skin and atherosclerosis. Physiochem Aspects Med Rev 1992, 3:1–121.

    Google Scholar 

  51. Sprecher DL: Skin cholesterol: a new method to predict angiographic disease. Circulation 2000, 102:II-857.

    Google Scholar 

  52. Larsson B, Olivercrona G, Ericson T: Lipids in human saliva. Arch Oral Biol 1996, 41:105–110.

    Article  PubMed  CAS  Google Scholar 

  53. Karjalainen S, Sewon L, Soderling E, et al.: Salivary cholesterol of healthy adults in relation to serum cholesterol concentration and oral health. J Dent Res 1997, 76:1637–1643.

    Article  PubMed  CAS  Google Scholar 

  54. Lindenthal B, Simatupang A, Dotti MT, et al.: Urinary excretion of mevalonic acid as an indicator of cholesterol synthesis. J Lipid Res 1996, 37:2193–2201.

    PubMed  CAS  Google Scholar 

  55. Nozaki S, Nakagawa T, Nakata A, et al.: Effects of pravastatin on plasma and urinary mevalonate concentrations in subjects with familial hypercholesterolemia: a comparison of morning and evening administration. Eur J Clin Pharmacol 1996, 49:361–364.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pacific Biometrics Research Foundation, 24415 SE 156 Street, 98027, Issaquah, WA, USA

    G. Russell Warnick MS, MBA & Alan T. Remaley MD, PhD

Authors
  1. G. Russell Warnick MS, MBA
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alan T. Remaley MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Warnick, G.R., Remaley, A.T. Measurement of cholesterol in plasma and other body fluids. Curr Atheroscler Rep 3, 404–411 (2001). https://doi.org/10.1007/s11883-001-0079-7

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11883-001-0079-7

Keywords

Search

Navigation